Budesonide, USP recall in Canada: May contain glass fragments
In plain language
This recall involves Budesonide, USP, an active pharmaceutical ingredient, sold in Canada. It's being recalled because the affected lot may contain a glass fragment. Consult your healthcare provider before stopping use and follow the return steps in the official notice.
What to do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use.
- Contact Medisca Pharmaceutique Inc. if you have questions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Budesonide, USP
Lot: 202323/H
Why this matters
Ingestion hazard from glass fragments
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 202323/H
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Ingestion hazard from glass fragments
What should consumers do?
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use. Contact Medisca Pharmaceutique Inc. if you have questions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Ingestion hazard from glass fragments
When was this product recalled?
This product was recalled on July 4, 2024.
Is the Medisca Pharmaceutique Inc. brand affected by this recall?
Yes, Medisca Pharmaceutique Inc. products are affected by this recall. This recall involves Budesonide, USP, an active pharmaceutical ingredient, sold in Canada. It's being recalled because the affected lot may contain a glass fragment. Consult your healthcare provider before stopping use and follow the return steps in the official notice.